FAQ
Bermuda’s national formulary is the list of common essential medications along with associated products and devices used in medical treatments, which are intended to be medically appropriate, cost-effective, and sold at a regulated price. See source referenced below. [1]
The national formulary highlights the medicines and medical products that are most effective for the treatment of the most prevalent medical conditions in Bermuda in order to:
- Promote rational medicines use; and
- Assist decision-makers who are working to ensure that essential medicines are available and affordable.
Essential medicines are those that satisfy the priority healthcare needs of the population. They are selected with due regard to public health relevance, evidence of efficacy and safety, and comparative cost-effectiveness.
Essential medicines are intended to be available within the context of functioning health systems at all times, in adequate amounts, in appropriate dosage forms, with assured quality and adequate information, and at a price, the individual and the community can afford. See source referenced below. [2]
The Pharmacy & Therapeutics committee is responsible for selecting items for inclusion on the formulary that are supported by the health needs of Bermuda’s population, appropriate standards of practice, peer-reviewed medical literature, and other factors.
No. This formulary in no way limits or changes the ability to prescribe, import, or sell any medications.
Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community. See source referenced below. [3]
Next steps
The Pharmacy & Therapeutics Committee is currently holding meetings on a regular basis to review medicines and medical products for additions to the National Formulary. Supporting information is currently being collected from stakeholders to support the creation of the formulary.
A series of educational campaigns for the public and stakeholders are forthcoming.
